商务合作
动脉网APP
可切换为仅中文
LAKEWOOD, Colo.--(
科罗拉多州莱克伍德--(
BUSINESS WIRE
商业热线
)--Vivo Infusion, a nationally recognized provider of accessible and affordable ambulatory infusion services, announced today it has acquired the Neurology Institute of San Antonio (“NISA”) and Vista Infusions (“Vista”) (collectively “the Company”), an industry leader in ambulatory infusion services and a leading neurological center of excellence.
)--Vivo Infusion是一家全国公认的可获得且价格合理的门诊输液服务提供商,今天宣布收购了圣安东尼奥神经病学研究所(“NISA”)和Vista Infusions(“Vista”)(统称为“公司”),这是一家门诊输液服务行业领军者和领先的神经系统卓越中心。
With this acquisition, Vivo Infusion will manage nearly 90 ambulatory infusion centers across 15 states. Financial terms of the transaction were not disclosed..
通过此次收购,维梧输液将管理15个州的近90个门诊输液中心。交易的财务条款未披露。。
Founded in 2003, the Company provides outstanding patient care to the local community and has grown in the greater San Antonio market through de novo center openings. The Company is a leader as the infusion provider of choice for patients suffering from multiple sclerosis and other neurological conditions.
该公司成立于2003年,为当地社区提供卓越的患者护理,并通过新中心的开设在圣安东尼奥大市场发展壮大。该公司是多发性硬化症和其他神经系统疾病患者首选输液供应商的领导者。
Following the transaction, Vivo will have 20 locations across Texas including infusion centers in Dallas, Houston, Longview, Tyler and San Antonio..
。。
“We are thrilled to continue to build on the reputation of NISA and Vista Infusions and welcome them into the Vivo family,” said Steve Rodgers, Chief Executive Officer of Vivo Infusion. “NISA and Vista continue Vivo’s emphasis as an infusion provider of choice for neurological and autoimmune diseases.
维梧输液首席执行官史蒂夫·罗杰斯(SteveRodgers)表示:“我们很高兴继续扩大NISA和Vista输液的声誉,并欢迎他们加入维梧大家庭。”。“NISA和Vista继续强调维梧作为神经系统疾病和自身免疫疾病的首选输液供应商。
We believe that by partnering with leading physician practices like that of Drs. Gazda and Neiman, we can advance the quality of care for patients while improving value. We are delighted to join forces with Drs. Gazda, Neiman, and the entire NISA and Vista teams.”.
我们相信,通过与Gazda博士和Neiman博士等领先的医生合作,我们可以提高患者的护理质量,同时提高价值。我们很高兴与加兹达博士、内曼博士以及整个NISA和Vista团队携手合作。”。
“I am excited to join the Vivo platform. We look forward to bringing Vivo and Vista together to deliver an industry-leading patient and provider experience,” said Dr. Suzanne Gazda. Dr. Gazda and Dr. Braden Neiman will continue practicing as neurologists with Vivo’s assistance in growth initiatives..
苏珊娜·加兹达博士说:“我很高兴加入维梧平台。我们期待着将维梧和Vista结合在一起,提供业界领先的患者和提供者体验。”。Gazda博士和Braden Neiman博士将在维梧的帮助下继续作为神经科医生执业,以促进增长。。
Fifth Third Securities served as the exclusive financial advisor to NISA and Vista Infusions for this transaction.
Fifth Third Securities担任NISA和Vista Infusions的独家财务顾问。
About Vivo Infusion
关于体内输注
Vivo Infusion is a leading provider of accessible, affordable, community-based infusion and injection care for patients suffering from compromised immune systems, cancer-related diagnoses, and other medical conditions. Vivo Infusion provides compassionate, expert care administered in safe, accessible facilities using efficient and cost-effective, patient-focused best practices.
Vivo Infusion是一家领先的供应商,为免疫系统受损,癌症相关诊断和其他医疗状况的患者提供可获得的,负担得起的,基于社区的输液和注射护理。Vivo输液使用高效且具有成本效益的以患者为中心的最佳实践,在安全,可访问的设施中提供富有同情心的专家护理。
Vivo currently serves communities in fifteen states, with plans to expand into additional markets. For more information, visit: .
维梧目前为15个州的社区提供服务,并计划扩展到其他市场。有关更多信息,请访问:。
https://vivoinfusion.com/
https://vivoinfusion.com/
.
.
About NISA and Vista Infusions
关于NISA和Vista输液
Neurology Institute of San Antonio and Vista Infusions is a leading provider of ambulatory infusion services and a neurological center of excellence providing service to patients throughout Texas. The Company specializes in long-term treatment of neurological conditions and has developed a reputation for high quality patient care, professionalism and management of complex conditions in an affordable and accessible setting.
圣安东尼奥和维斯塔输注神经病学研究所是门诊输注服务的领先供应商,也是为德克萨斯州患者提供服务的卓越神经病学中心。该公司专门从事神经系统疾病的长期治疗,并以高质量的患者护理,专业精神和在负担得起且易于获得的环境中管理复杂疾病而闻名。
For more information, please visit: .
。
https://www.vistainfusions.com/
https://www.vistainfusions.com/
.
.